SMARCA4 and ovarian neoplasm: To conclude, BRG1 is a novel immunohistochemical diagnostic marker which can clinch the diagnosis in suspected cases of SCCOHT, and should be included in the immunohistochemical evaluation of polyphenotypic ovarian tumors in young females.